Skip to main content
. 2020 Jan 22;26(6):727–735. doi: 10.5603/CJ.a2018.0142

Table 2.

Patient clinical data of the groups.

Acetylsalicylic acid Control group

Morning Evening
Coronary heart disease 58 56 0
Arterial hypertension 58 56 61
Diabetes mellitus 15 17 14
Metabolic syndrome 21 20 22
History of myocardial infarction 12 13 0
Previous ischemic stroke or transient cerebral ischemia 5 6 0
History of coronary artery bypass surgery 8 9 0
History of coronary angioplasty 38 37 0
Hyperlipidemia 58 56 61
Atherosclerosis of the lower limbs 7 6 5
Chronic obstructive pulmonary disease 6 7 5
Thyroid disease 4 5 6